The utility of basic blood counts, WBC histogram and C-reactive protein in detecting malaria.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
26 Sep 2021
Historique:
received: 06 09 2020
accepted: 16 09 2021
entrez: 27 9 2021
pubmed: 28 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Hematology analyzers display abnormal parameters during malaria infection providing insightful information for suspecting and assessing malaria infection. The goal of this study is to demonstrate the potential of a three-part differential hematology analyzer to assess malaria, provide information about the parasitemia, and discuss the importance of combining C-reactive protein (CRP) with hematology parameters to obtain further information about the malaria infection. The present study shows the results of a case-control study during the monsoon season of years 2018 and 2019 in Mumbai, India. The study considers 1008 non-malaria febrile cases, 209 P. vivax and 31 P. falciparum positive malaria samples, five cases of mixed P. vivax and P. falciparum infection, and three co-infection cases of P. vivax and dengue. Raw data from the three-part analyzer LC-667G CRP (HORIBA) and the corresponding microscopic findings (golden standard for diagnosis of malaria) were obtained for each sample. The medians of platelet counts (PLT) were 102.5, 109.0, and 223.0 × 10 A three-part differential hematology analyzer has the potential to not only trigger malaria diagnosis confirmation but also assess the severity of the infection when CRP is considered.

Sections du résumé

BACKGROUND BACKGROUND
Hematology analyzers display abnormal parameters during malaria infection providing insightful information for suspecting and assessing malaria infection. The goal of this study is to demonstrate the potential of a three-part differential hematology analyzer to assess malaria, provide information about the parasitemia, and discuss the importance of combining C-reactive protein (CRP) with hematology parameters to obtain further information about the malaria infection.
METHODS METHODS
The present study shows the results of a case-control study during the monsoon season of years 2018 and 2019 in Mumbai, India. The study considers 1008 non-malaria febrile cases, 209 P. vivax and 31 P. falciparum positive malaria samples, five cases of mixed P. vivax and P. falciparum infection, and three co-infection cases of P. vivax and dengue. Raw data from the three-part analyzer LC-667G CRP (HORIBA) and the corresponding microscopic findings (golden standard for diagnosis of malaria) were obtained for each sample.
RESULTS RESULTS
The medians of platelet counts (PLT) were 102.5, 109.0, and 223.0 × 10
CONCLUSIONS CONCLUSIONS
A three-part differential hematology analyzer has the potential to not only trigger malaria diagnosis confirmation but also assess the severity of the infection when CRP is considered.

Identifiants

pubmed: 34565334
doi: 10.1186/s12879-021-06704-5
pii: 10.1186/s12879-021-06704-5
pmc: PMC8474782
doi:

Substances chimiques

C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1006

Informations de copyright

© 2021. The Author(s).

Références

Malar J. 2010 Nov 30;9:346
pubmed: 21118557
Cureus. 2018 Sep 27;10(9):e3376
pubmed: 30510885
PLoS One. 2018 Aug 6;13(8):e0201693
pubmed: 30080904
Ann Hematol. 2005 Jun;84(6):400-2
pubmed: 15616813
Clin Diagn Lab Immunol. 1994 Jul;1(4):437-44
pubmed: 8556482
Hematology. 2013 Mar;18(2):101-5
pubmed: 22980408
Clin Lab Haematol. 2004 Dec;26(6):367-72
pubmed: 15595992
Clin Microbiol Infect. 2011 Nov;17(11):1624-31
pubmed: 21910780
Hematology. 2012 Mar;17(2):106-14
pubmed: 22664049
Am J Clin Pathol. 2006 Nov;126(5):691-8
pubmed: 17050066
J Clin Pathol. 1991 Mar;44(3):228-31
pubmed: 1707416
Indian J Pathol Microbiol. 2012 Oct-Dec;55(4):467-73
pubmed: 23455781
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):535-7
pubmed: 26065879
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2420
pubmed: 24069477
J Clin Diagn Res. 2015 Oct;9(10):EC05-8
pubmed: 26557525
Infect Dis Poverty. 2017 Mar 2;6(1):27
pubmed: 28249623
Acta Trop. 2016 Dec;164:425-430
pubmed: 27751864
Int J Mol Sci. 2014 Nov 03;15(11):19952-61
pubmed: 25372941
PLoS One. 2015 Mar 25;10(3):e0121057
pubmed: 25807235
Malar J. 2010 Jan 13;9:13
pubmed: 20070895
Malar J. 2014 Jun 05;13:218
pubmed: 24898891
Oman Med J. 2014 Jan;29(1):12-7
pubmed: 24498476
Malar J. 2019 Jul 31;18(1):262
pubmed: 31366365
East Afr Med J. 2014 Jan;91(1):1-7
pubmed: 26862629
Malar J. 2012 Aug 28;11:301
pubmed: 22929647
Br J Haematol. 1999 Mar;104(3):499-503
pubmed: 10086786
Adv Biomed Res. 2012;1:41
pubmed: 23326772
Science. 2009 Feb 6;323(5915):797-800
pubmed: 19197068
Mem Inst Oswaldo Cruz. 2012 Dec;107(8):1035-41
pubmed: 23295755
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:52-63
pubmed: 21881757
Infect Drug Resist. 2019 Mar 05;12:521-527
pubmed: 30881057
Blood. 2018 Sep 20;132(12):1332-1344
pubmed: 30026183
Trans R Soc Trop Med Hyg. 1996 Jan-Feb;90(1):10-4
pubmed: 8730300

Auteurs

Jun Nishimura (J)

Horiba Medical, Kyoto, Japan. jun.nishimura@horiba.com.

Parag Dharap (P)

Dharap's Diagnostic Center, Mumbai, India.

Sebastien Raimbault (S)

Horiba Medical, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH